Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage

American Journal of Pathology

Volumn 173, Issue 1, 2008, Pages 161-169

  Dejica, Valeria M ^a,e   Mort, John S ^a   Laverty, Sheila ^c   Percival, M David ^d   Antoniou, John ^b   Zukor, David J ^b   Poole, A Robin ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^e SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 2; COLLAGENASE 3;

ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR CONDYLE; HUMAN; HUMAN TISSUE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 46749086701     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070494     Document Type: Article

References (30)

1. Dodge GR, Poole AR: Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989, 83:647-661
2. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR: Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545
3. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996, 97:761-768
4. Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, Van Wart HE, Poole AR: Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000, 43:673-682
5. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994, 93:1722-1732
6. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR: Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995, 96:2859-2869
7. Kempson GE: Relationship between the tensile properties of articular cartilage from the human knee and age. Ann Rheum Dis 1982, 41:508-511
8. Miller EJ, Harris ED Jr, Chung E, Finch JE Jr, McCroskery PA, Butler WT: Cleavage of type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemistry 1976, 15:787-792
9. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP: Human cathepsin K cleaves native type I and II collagens at the Nterminal end of the triple helix. Biochem J 1998, 331:727-732
10. Li Z, Hou WS, Brömme D: Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 2000, 39:529-536
11. Hou WS, Li Z, Buttner FH, Bartnik E, Bromme D: Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 2003, 384:891-897
12. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaissé JM: The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352
13. Brömme D, Okamoto K, Wang BB, Biroc S: Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 1996, 271:2126-2132
14. Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljestrom M, Hukkanen M, Takagi M, Virtanen I, Santavirta S: Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 2002, 46:953-960
15. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049
16. Billinghurst RC, Ionescu M, Poole AR: Immunoassay for collagenase-mediated cleavage of types I and II collagens. Methods Mol Biol 2001, 151:457-472
17. Mort JS, Roughley PJ: Production of antibodies against degradative neoepitopes in aggrecan. Methods in Molecular Medicine, vol 100: Cartilage and Osteoarthritis, vol. 1: Cellular and Molecular Tools. Edited by Sabatini M, Pastoureau P, De Ceuninck F. Totowa, Humana Press, 2004, pp 237-249
18. Billington CJ, Mason P, Magny M-C, Mort JS: The slow-binding inhibition of cathepsin K by its propeptide. Biochem Biophys Res Commun 2000, 276:924-929
19. Li CS, Deschenes D, Desmarais S, Falgueyret JP, Gauthier JY, Kimmel D, Léger S, Masse F, McGrath ME, McKay DJ, Percival MD, Riendeau D, Rodan SB, Thërien M, Truong V-L, Wesolowski G, Zamboni R, Black WC: Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorg Med Chem Lett 2006, 16:1985-1989
20. Poole AR, Ionescu M, Fitzcharles MA, Billinghurst RC: The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 2004, 294:145-153
21. Gunja-Smith Z, Woessner JF Jr: Activation of cartilage stromelysin-1 at acid pH and its relation to enzyme pH optimum and osteoarthritis. Agents Actions 1993, 40:228-231
22. Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 833:173-177
23. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, Van Wart H, Poole AR: Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum 2000, 43:664-672
24. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR: Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135
25. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410
26. Nagase H, Fields GB: Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 1996, 40:399-416
27. Shi G-P, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ: Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 1995, 357:129-134
28. Brömme D, Okamoto K: Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary. Molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe-Seyler 1995, 376:379-384
29. Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Brömme D: Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem 2002, 277:28669-28676
30. Rawlings ND, Morton FR, Barrett AJ: MEROPS: the peptidase database. Nucleic Acids Res 2006, 34(Suppl 1):D270-D272